5: Pelvic pain
CHAPTER 5 Pelvic pain Jane Moore Nuffield Department of Obstetrics and Gynecology, University of Oxford, Oxford, UK Case scenario A 27‐year‐old woman, para 2, attends the gynecology clinic complaining of…
Urine metabolomics and proteomics in prenatal health
Urine metabolomics and proteomics in prenatal health Daniela Duarte, Maria do Céu Almeida, Pedro Domingues, and Ana M. Gil Main prenatal disorders and challenges related to clinical diagnosis Pregnancy-related disorders comprise maternal and fetal…
Metabolomics and perinatal asphyxia
Metabolomics and perinatal asphyxia Ernesto d’Aloja, Emanuela Locci, Antonio Noto, Matteo Nioi, Giovanni Bazzano, and Vassilios Fanos Introduction The incidence of neonatal encephalopathy worldwide is still elevated, with a magnitude…
Omics and perinatal medicine
Omics and perinatal medicine Preeclampsia Piya Chaemsaithong and Liona C. Poon Preeclampsia: Disease theory Preeclampsia (PE) is a multisystem disorder of pregnancy traditionally characterized by the onset of hypertension with…
Cost of pregnancy complications related to noncommunicable diseases and cost effectiveness of interventions to address them
Cost of pregnancy complications related to noncommunicable diseases and cost effectiveness of interventions to address them Anil Kapur, Jon Hyett, and H. David McIntyre Brief introduction to health economics and cost-effectiveness analysis…
Microarrays
Microarrays Melissa Stosic, Jessica L. Giordano, Brynn Levy, and Ronald Wapner Introduction Chromosomal microarray analysis (CMA) by which chromosomal anomalies beyond the resolution of traditional karyotyping can be identified has…
Metabolomics in normal and pathologic pregnancies
Metabolomics in normal and pathologic pregnancies Antonio Ragusa, Alessandro Svelato, and Sara D’Avino Metabolomics in normal pregnancies The definition of metabolomics is still in flux, and hence, different researchers provide slightly…
